Winton Group’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-528	Closed	-$101K	–	1758
2019 Q3	$101K	Buy	+528	New	+$101K	﹤0.01%	1464
2019 Q2	–	Sell	-479	Closed	-$96K	–	1275
2019 Q1	$96K	Buy	+479	New	+$96K	﹤0.01%	1033